| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 17-AAG | FIMM | pan-cancer | AAC | 0.038 | 0.8 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | 0.0078 | 0.8 |
| mRNA | carboplatin:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0077 | 0.9 |
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.9 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | 0.0076 | 0.9 |
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | -0.032 | 0.9 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.0064 | 0.9 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | 0.0078 | 0.9 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | 0.0075 | 0.9 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.0061 | 0.9 |